- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Prism Medico and Pharmacy's upcoming Annual General Meeting includes a major strategic shift. The company proposes to reallocate 23 Cr from a preferential issue, initially planned for a new manufacturing plant, to acquire a controlling 71.32% stake in Infuze Well Private Limited (IWPL), making it a subsidiary. This move is aimed at faster manufacturing capacity expansion with lower execution risk. IWPL is currently owned by the Whole-Time Director and her family, making this a material related party transaction. Shareholders will also consider approving the annual financial results and other related party transactions up to 70 Cr for the financial year.